105 related articles for article (PubMed ID: 25812371)
1. [Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment].
Hamaguchi T; Sadahiro K; Satoh T
Nihon Rinsho; 2015 Mar; 73(3):447-52. PubMed ID: 25812371
[TBL] [Abstract][Full Text] [Related]
2. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
Pitocco D; Rizzi A; Scavone G; Tanese L; Zaccardi F; Manto A; Ghirlanda G
Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
[TBL] [Abstract][Full Text] [Related]
3. Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review.
Kerr D; Wizemann E; Senstius J; Zacho M; Ampudia-Blasco FJ
J Diabetes Sci Technol; 2013 Nov; 7(6):1595-606. PubMed ID: 24351186
[TBL] [Abstract][Full Text] [Related]
4. Addressing hyperglycemia from hospital admission to discharge.
Moghissi ES
Curr Med Res Opin; 2010 Mar; 26(3):589-98. PubMed ID: 20078323
[TBL] [Abstract][Full Text] [Related]
5. What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.
Heise T; Piras de Oliveira C; Juneja R; Ribeiro A; Chigutsa F; Blevins T
Diabetes Obes Metab; 2022 Sep; 24(9):1689-1701. PubMed ID: 35593434
[TBL] [Abstract][Full Text] [Related]
6. Continuous subcutaneous insulin infusion with short-acting insulin analogues or human regular insulin: efficacy, safety, quality of life, and cost-effectiveness.
Radermecker RP; Scheen AJ
Diabetes Metab Res Rev; 2004; 20(3):178-88. PubMed ID: 15133748
[TBL] [Abstract][Full Text] [Related]
7. Accelerating and improving the consistency of rapid-acting analog insulin absorption and action for both subcutaneous injection and continuous subcutaneous infusion using recombinant human hyaluronidase.
Muchmore DB; Vaughn DE
J Diabetes Sci Technol; 2012 Jul; 6(4):764-72. PubMed ID: 22920800
[TBL] [Abstract][Full Text] [Related]
8. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
9. Type 1 diabetes mellitus: effective insulin strategies with less hypoglycemia.
Bolli GB
Postgrad Med; 2004 Nov; 116(5 Suppl Exploring):13-20. PubMed ID: 19667675
[TBL] [Abstract][Full Text] [Related]
10. Glycemic control in pregnant diabetic women using a continuous subcutaneous insulin infusion pump.
Cohen AW; Liston RM; Mennuti MT; Gabbe SG
J Reprod Med; 1982 Oct; 27(10):651-4. PubMed ID: 7175835
[TBL] [Abstract][Full Text] [Related]
11. Insulin biosimilars: the impact on rapid-acting analogue-based therapy.
Franzè S; Cilurzo F; Minghetti P
BioDrugs; 2015 Apr; 29(2):113-21. PubMed ID: 25773234
[TBL] [Abstract][Full Text] [Related]
12. A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy.
Durnwald CP; Landon MB
J Matern Fetal Neonatal Med; 2008 May; 21(5):309-13. PubMed ID: 18446657
[TBL] [Abstract][Full Text] [Related]
13. Insulin analogs: Glimpse on contemporary facts and future prospective.
Sharma AK; Taneja G; Kumar A; Sahu M; Sharma G; Kumar A; Sardana S; Deep A
Life Sci; 2019 Feb; 219():90-99. PubMed ID: 30639280
[TBL] [Abstract][Full Text] [Related]
14. Evolution of insulin development: focus on key parameters.
Tibaldi JM
Adv Ther; 2012 Jul; 29(7):590-619. PubMed ID: 22843207
[TBL] [Abstract][Full Text] [Related]
15. Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience.
Hermansen K; Bohl M; Schioldan AG
Drugs; 2016 Jan; 76(1):41-74. PubMed ID: 26607485
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine.
Bode BW
Endocr Pract; 2011; 17(2):271-80. PubMed ID: 21134878
[TBL] [Abstract][Full Text] [Related]
17. Moving toward the ideal insulin for insulin pumps.
Cengiz E; Bode B; Van Name M; Tamborlane WV
Expert Rev Med Devices; 2016; 13(1):57-69. PubMed ID: 26560137
[TBL] [Abstract][Full Text] [Related]
18. New strategies for glucose control in patients with type 1 and type 2 diabetes mellitus in pregnancy.
Gabbe SG; Carpenter LB; Garrison EA
Clin Obstet Gynecol; 2007 Dec; 50(4):1014-24. PubMed ID: 17982345
[TBL] [Abstract][Full Text] [Related]
19. [The comparison of insulin aspart and human soluble insulin used in insulin pump therapy in newly diagnosed type 2 diabetic patients].
Li YB; Liu J; Liao ZH; Liao Y; Deng WP; Weng JP
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2472-6. PubMed ID: 16321271
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences.
Home PD
Diabetes Obes Metab; 2012 Sep; 14(9):780-8. PubMed ID: 22321739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
